Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 4/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.50 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.47 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9694221 | 0.91 | ABCB11 (0.47) | TRPA1PTGS2GRIA4FFAR1 | |
| SCHEMBL1260 | 0.86 | TRPA1 (0.68) | TRPA1TAAR1 | |
| SCHEMBL61000 | 0.86 | TRPA1 (0.68) | TRPA1TAAR1 | |
| SCHEMBL60429 | 0.86 | TRPA1 (0.68) | TRPA1TAAR1 | |
| SCHEMBL9694205 | 0.84 | FFAR1 (0.46) | TRPA1GRIA4FFAR1 | |
| SCHEMBL8976575 | 0.84 | TRPA1 (0.65) | TRPA1TAAR1 | |
| Hydrochloric Acid SCHEMBL28757862 | 0.84 | TRPA1 (0.65) | TRPA1TAAR1 | |
| Methane SCHEMBL27517092 | 0.84 | TRPA1 (0.65) | TRPA1TAAR1 | |
| Ammonia Solution, Strong SCHEMBL28122152 | 0.84 | TRPA1 (0.65) | TRPA1TAAR1 | |
| SCHEMBL8939138 | 0.84 | TRPA1 (0.65) | TRPA1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6133446-A | Heterocyclic compounds for the treatment of CNS and cardiovascular disorders | PHARMACIA & UPJOHN COMPANY (US) | 2000-10-17 | — | — | US | disclosed |
| EP-0806417-B1 | Novel optically active benzene derivatives, process for producing the same and liquid-crystalline composition containing said derivatives as liquid-crystalline compound and light switching elements | SUMITOMO CHEMICAL CO (JP) | 2000-03-08 | — | — | EP | disclosed |
| EP-0737189-B1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS | UPJOHN CO (US) | 1999-07-28 | — | — | EP | disclosed |
| US-5877317-A | Heterocyclic compounds for the treatment of CNS and cardiovascular disorders | PHARMACIA & UPJOHN COMPANY (US) | 1999-03-02 | — | — | US | disclosed |
| US-5693251-A | LIQUID CRYSTAL DISPLAYS; HIGH SPEED RESPONSE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1997-12-02 | — | — | US | disclosed |
| EP-0806417-A1 | Novel optically active benzene derivatives, process for producing the same and liquid-crystalline composition containing said derivatives as liquid-crystalline compound and light switching elements | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1997-11-12 | — | — | EP | disclosed |
| EP-0737189-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS | PHARMACIA & UPJOHN COMPANY (US) | 1996-10-16 | — | — | EP | disclosed |
| WO-1995018118-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS | THE UPJOHN COMPANY (US) | 1995-07-06 | — | — | WO | disclosed |
| US-5389293-A | Light switches | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-02-14 | — | — | US | disclosed |
| EP-0360622-A2 | Novel optically active benzene derivatives, process for producing the same and liquid-crystalline composition containing said derivatives as liquid-crystalline compound and light switching elements | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-03-28 | — | — | EP | disclosed |
| US-4011336-A | ANTIPHLOGISTIC AGENTS | BASF AKTIENGESELLSCHAFT (DT) | 1977-03-08 | — | — | US | disclosed |